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Abstract 
 
Papillary Thyroid Carcinoma (PTC) is the most common type of thyroid malignancy making up to 70-80% of all 
thyroid malignancies. PTC presenting with extrathyroidal cutaneous fungating mass is unusual. We report the 
management of a neglected fungatingPTC in a 70yr old female.  After thorough preoperative evaluation,she 
underwent total thyroidectomy with en-bloc resection of the fungating mass along with adequate skin margin and 
ipsilateral selective neck dissection. Postoperative period was uneventful. 
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Introduction  
Papillary Thyroid Carcinoma (PTC) is the most 
common thyroid malignancy. PTC is often multifocal 
and metastasizes to regional lymph nodes in about 40% 
of cases. Distant metastasis of PTC is rare and usually 
involves the lungs, liver, bones, and brain. Cutaneous 
metastases occur in 0.6-10.4% of all patients with 
cancer and represent 2% of all skin tumours.[1] 
Papillary thyroid carcinoma is a slow growing 
neoplasm which explains the relatively long duration 
until a diagnosis is established. Appropriate early 
surgical treatment decreases the risk of metastasis and 
recurrence. We report the management of a very rare 
case of neglected papillary carcinoma thyroid 
presenting with cutaneous fungating mass. 
 
Case report 
A 70yrs old female patient was referred to our OPD 
with complaints of long standing neck swelling since 
15yrs which developed into a fungatingmass 3weeks 
prior to presenting at our OPD. It is associated with 
ocassional bouts of bleeding for which she presented to 
us. 
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No other symptoms of pain, difficulty in swallowing, 
hoarseness of voice or dyspnea noted (Fig. 1). 
On further evaluation FNAC done suggestive of 
papillary carcinoma. Biopsy from the fungating mass 
done suggested the same. IDL showed normal vocal 
cords. CT neck suggestive of mass arising from left 
lobe of thyroid with enlarged lymphnodes without 
tracheal and carotid sheath infiltration. Patient was 
anaemic so 1unit of packed cells are transfused 
preoperatively and 2 units are kept as reserve. After 
thorough cardiopulmonary evaluation and discussing 
with our anaesthesia team, Patient was posted for 
surgery after explaining the procedure and risks 
associated to the patient and his attendents.  An 
elliptical neck incision was made, taking the entire 
fungating mass together with a good healthy skin 
margin. Intraoperative findings revealed that the 
fungating mass arising from left lobe of thyroid, there 
is no infiltration to the strap muscles and 
sternocleidomastoid. Carotids and IJV are not 
involved. Ipsilateral central neck node dissection done. 
Bilateral RLN are preserved. The skin cover over the 
defect in lower neck was maintained after mobilizing 
the local skin flap (Fig 2 & Fig 3). The histopathology 
report confirmed the diagnosis of papillary thyroid 
carcinoma. Postoperative vocal cord assessment 
revealed no obvious palsy of the vocal cords.  The 
patient underwent radioiodine ablation therapy 4 weeks 
later. 
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Discussion  
PTC is the most common malignancy of thyroid gland. 
Well-differentiated PTC has an excellent prognosis, 
with a 5-year survival rate of greater than 
97%.[2]Extrathyroidal extension is seen in 4 to 16 
percent of cases and carries with it an increased risk of 
disease recurrence and reduces overall survival 
rate.[3]Extrathyroidal extension involves invasion of 
trachea, oesophagus, recurrent laryngeal nerve, strap 
muscles and skin. Cutaneous metastasis from thyroid 
carcinoma is rare. It usually occurs in the setting of 
disseminated neoplastic disease. [4] Dahl et al 
reviewed the English literature from 1964 onwards and 
found 43 cases of thyroid carcinoma with skin 
metastases. They found that papillary carcinoma was 
the most common thyroid cancer to result in skin 
metastases, representing 41% of cases, followed by 
follicular carcinoma at 28%, with anaplastic carcinoma 
and medullary carcinoma each contributing 15% of 
cases.The scalp is the most frequent cutaneous site of 
metastasis from carcinoma thyroid. The other 
cutaneous sites involved with lesser frequency are the 
       Fig 2: Lesion at the time of Surgery 
Fig1: Fungating Thyroid Cancer 
         Fig 3: Immediate Post-operative progress 
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cheeks, shoulders, arms, abdomen, and thighs. 
Cutaneous metastases may either be the initial 
manifestation of thyroid carcinoma or can be the first 
evidence of recurrence of thyroid carcinoma. The skin 
metastasis of PTC is mostly associated with aggressive 
and disseminated disease and shows a poor outcome, 
especially when associated with BRAFV600E 
mutations.[4,5,6] A progressive loss of differentiation 
is usually found in these tumors, leading to a loss in 
their iodine concentrating ability,thereby making them 
unresponsive to radioiodine therapy. 
 
Large fungating thyroidal masses are extremely rare 
and present a unique challenge to surgeons. These large 
masses often present in close proximity to or may 
involve a number of critical anatomical structures. 
Hence, before contemplating surgery, it is essential to 
perform a thorough work-up and assessment of the 
relevant anatomy and pathology. Most important in the 
preoperative diagnostic evaluation is to exclude 
anaplastic thyroid cancer, which has a dismal outcome 
and prognosis. PTC has favourable outcome even with 
cutaneous involvement.  
 
A total thyroidectomy along with complete resection of 
the cutaneous mass and removal of the involved 
structures including cervical lymph nodes, followed by 
radioiodine ablation is the accepted management of 
PTC with extrathyroidal extension. Fujimoto Y et al. 
performed aggressive radical resection on 18 of 21 
elderly patients with locally invasive-papillary 
carcinoma of the thyroid and advocated aggressive 
resection for control of locally advanced, differentiated 
carcinoma of the thyroid.[7] Skin loss can either be 
closed primarily as in our case, or may require a 
flap.[8] In the experienced hands, permanent 
complications such as recurrent laryngeal nerve injury 
and hypoparathyroidism occurs at a rate of less than 
2%.[9] 
 
Conclusion 
In conclusion large fungating thyroid carcinoma 
remain a unique challenge to surgeon and requires a 
thorough preoperative evaluation and work-up as each 
case differs from others. Surgery should address the 
primary disease, cutaneous spread, the nodal 
involvement and the involvement of the adjacent 
extrathyroidal structures. Post-operative radio-iodine 
ablation and suppressive doses of thyroxine and regular 
follow-up are also essential. 
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